Helicobacter pylori strain FDAARGOS_300

Helicobacter pylori strain FDAARGOS_300 is a Gram-negative, microaerophilic bacterium characterized by its spirilla shape and presence of flagella. This organism is adapted to a host-associated habitat, primarily colonizing the gastric mucosa of various hosts, including Homo sapiens, Gallus gallus, and other mammals and avians. It exists as single cells and is classified as free-living, despite its dependence on host environments for survival and reproduction. The strain thrives optimally at 37°C and falls within the mesophilic temperature range. It possesses a single replicon and has a double-membrane structure. The pathogenicity of H. pylori strain FDAARGOS_300 is particularly significant in humans, as it is associated with various gastrointestinal diseases and health issues. Notably, it has been linked to chronic gastric inflammation, gastric ulcers, and several forms of gastric cancer, including adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. This bacterium can also induce asymptomatic mucosal inflammatory responses and is implicated in conditions such as GERD and functional dyspepsia. The ecological insight provided by these traits indicates that H. pylori plays a crucial role in the complex interactions between host organisms and their microbiomes, particularly in the context of gastric health and disease. Its prevalence across multiple host species highlights its adaptability and significance in the study of infectious diseases and cancer biology. The accessions related to this strain, such as NZ_CP027404.1, facilitate further research into its genomic characteristics and pathogenic mechanisms.